716 related articles for article (PubMed ID: 20397896)
1. Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article.
Stummer W; Tonn JC; Mehdorn HM; Nestler U; Franz K; Goetz C; Bink A; Pichlmeier U;
J Neurosurg; 2011 Mar; 114(3):613-23. PubMed ID: 20397896
[TBL] [Abstract][Full Text] [Related]
2. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma.
Tsugu A; Ishizaka H; Mizokami Y; Osada T; Baba T; Yoshiyama M; Nishiyama J; Matsumae M
World Neurosurg; 2011; 76(1-2):120-7. PubMed ID: 21839963
[TBL] [Abstract][Full Text] [Related]
3. Endoscopic-assisted visualization of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery: a technical note.
Rapp M; Kamp M; Steiger HJ; Sabel M
World Neurosurg; 2014; 82(1-2):e277-9. PubMed ID: 23871813
[TBL] [Abstract][Full Text] [Related]
4. Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.
Roder C; Bisdas S; Ebner FH; Honegger J; Naegele T; Ernemann U; Tatagiba M
Eur J Surg Oncol; 2014 Mar; 40(3):297-304. PubMed ID: 24411704
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence-guided resection of primary and recurrent malignant gliomas with 5-aminolevulinic acid. Preliminary results.
Tykocki T; Michalik R; Bonicki W; Nauman P
Neurol Neurochir Pol; 2012; 46(1):47-51. PubMed ID: 22426762
[TBL] [Abstract][Full Text] [Related]
6. Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 1: Clinical, radiological and pathological studies.
Colditz MJ; Jeffree RL
J Clin Neurosci; 2012 Nov; 19(11):1471-4. PubMed ID: 22959448
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of fluorescence-guided resection of recurrent gliomas using five-aminolevulinic acid: retrospective analysis of surgical and neurological outcome in 58 patients.
Hickmann AK; Nadji-Ohl M; Hopf NJ
J Neurooncol; 2015 Mar; 122(1):151-60. PubMed ID: 25557106
[TBL] [Abstract][Full Text] [Related]
8. Observational, retrospective study of the effectiveness of 5-aminolevulinic acid in malignant glioma surgery in Spain (The VISIONA study).
Díez Valle R; Slof J; Galván J; Arza C; Romariz C; Vidal C;
Neurologia; 2014 Apr; 29(3):131-8. PubMed ID: 23870657
[TBL] [Abstract][Full Text] [Related]
9. 5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastoma.
Schucht P; Knittel S; Slotboom J; Seidel K; Murek M; Jilch A; Raabe A; Beck J
Acta Neurochir (Wien); 2014 Feb; 156(2):305-12; discussion 312. PubMed ID: 24449075
[TBL] [Abstract][Full Text] [Related]
10. Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article.
Roberts DW; Valdés PA; Harris BT; Fontaine KM; Hartov A; Fan X; Ji S; Lollis SS; Pogue BW; Leblond F; Tosteson TD; Wilson BC; Paulsen KD
J Neurosurg; 2011 Mar; 114(3):595-603. PubMed ID: 20380535
[TBL] [Abstract][Full Text] [Related]
11. Association of 5-aminolevulinic acid fluorescence guided resection with photodynamic therapy in recurrent glioblastoma: a matched cohort study.
da Silva EB; Vasquez MWM; de Almeida Teixeira BC; Neto MC; Sprenger F; Filho JLN; Almeida-Lopes L; Ramina R
Acta Neurochir (Wien); 2024 May; 166(1):212. PubMed ID: 38739282
[TBL] [Abstract][Full Text] [Related]
12. Intraoperative monopolar mapping during 5-ALA-guided resections of glioblastomas adjacent to motor eloquent areas: evaluation of resection rates and neurological outcome.
Schucht P; Seidel K; Beck J; Murek M; Jilch A; Wiest R; Fung C; Raabe A
Neurosurg Focus; 2014 Dec; 37(6):E16. PubMed ID: 25434385
[TBL] [Abstract][Full Text] [Related]
13. Insular glioma resection: assessment of patient morbidity, survival, and tumor progression.
Sanai N; Polley MY; Berger MS
J Neurosurg; 2010 Jan; 112(1):1-9. PubMed ID: 19612970
[TBL] [Abstract][Full Text] [Related]
14. Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring.
Feigl GC; Ritz R; Moraes M; Klein J; Ramina K; Gharabaghi A; Krischek B; Danz S; Bornemann A; Liebsch M; Tatagiba MS
J Neurosurg; 2010 Aug; 113(2):352-7. PubMed ID: 19911888
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.
Stummer W; Pichlmeier U; Meinel T; Wiestler OD; Zanella F; Reulen HJ;
Lancet Oncol; 2006 May; 7(5):392-401. PubMed ID: 16648043
[TBL] [Abstract][Full Text] [Related]
16. Dual-labeling with 5-aminolevulinic acid and fluorescein for fluorescence-guided resection of high-grade gliomas: technical note.
Suero Molina E; Wölfer J; Ewelt C; Ehrhardt A; Brokinkel B; Stummer W
J Neurosurg; 2018 Feb; 128(2):399-405. PubMed ID: 28338432
[TBL] [Abstract][Full Text] [Related]
17. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
Li YM; Suki D; Hess K; Sawaya R
J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
[TBL] [Abstract][Full Text] [Related]
18. 5-aminolevulinic acid (5-ALA) fluorescence guided surgery of high-grade gliomas in eloquent areas assisted by functional mapping. Our experience and review of the literature.
Della Puppa A; De Pellegrin S; d'Avella E; Gioffrè G; Rossetto M; Gerardi A; Lombardi G; Manara R; Munari M; Saladini M; Scienza R
Acta Neurochir (Wien); 2013 Jun; 155(6):965-72; discussion 972. PubMed ID: 23468036
[TBL] [Abstract][Full Text] [Related]
19. 5-Aminolevulinic acid fluorescence guided resection of malignant glioma: Hong Kong experience.
Chan DTM; Yi-Pin Sonia H; Poon WS
Asian J Surg; 2018 Sep; 41(5):467-472. PubMed ID: 28844780
[TBL] [Abstract][Full Text] [Related]
20. [Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant gliomas--a new treatment modality].
Cortnum S; Laursen R
Ugeskr Laeger; 2013 Feb; 175(9):570-3. PubMed ID: 23608006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
